Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Nykode Tolerance A/S
A/S
Active
CVR 45048284
Gammel Lundtoftevej 1E
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2024
— employees
www.nykode.com
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit
—
EBITDA — year on year
DKK millions
NaNM
-InfinityM
-InfinityM
-InfinityM
-InfinityM
Key figures
Annual report
Revenue
—
—
EBITDA
—
—
Net profit
—
—
Total assets
—
—
Equity
—
—
Employees
—
—
Company information
Legal name
Nykode Tolerance A/S
CVR number
45048284
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30. august 2024
Share capital
DKK 400.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
—
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et bestyrelsesmedlem i forening med en direktør.
Company purpose
Selskabets formål er at forske i, udvikle og fremstille biofarmaceutiske produkter samt anden i forbindelse hermed stående virksomhed
Contact
Address
Gammel Lundtoftevej 1E
Email
info@nykode.com
Website
www.nykode.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Lyngby-Taarbæk
All Denmark companies
Revenue
DKK millions
EBITDA
DKK millions
Income statement
DKK thousands
Item
Revenue
Staff expenses
EBITDA
Depreciation & amort.
EBIT
Net financials
Profit before tax
Tax
Net profit
Balance sheet
DKK thousands
Item
Total assets
Equity
Long-term debt
Short-term debt
Total debt
Financial ratios
5-year trend
EBITDA margin
%
This company
15.8%
Market median
-NaN% vs market
Equity ratio
%
This company
38.2%
Market median
-NaN% vs market
Return on equity
%
This company
18.4%
Market median
-NaN% vs market
Net profit margin
%
This company
8.1%
Market median
-NaN% vs market
Asset turnover
×
This company
1.12×
Market median
-NaN% vs market
Debt / equity
×
This company
0.62×
Market median
-NaN% vs market
Annual reports & filings
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
AB
Agnete Brunsvik Fredriksen
Management
Management
2024
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
LS
Louise Stubbe
Board of Directors
2024
—
—
MT
Michael Thyrring Engsig
Chairman
2024
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nykode Therapeutics ASA
Individual
100.0%
100.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Nykode Tolerance A/S also hold positions in
0
other companies.
Person
Role here
Other companies
Agnete Brunsvik Fredriksen
Management
0 companies
Louise Stubbe
Board of Directors
0 companies
Michael Thyrring Engsig
Chairman
0 companies